Search Genes

GET /api/v1/genes/?format=api&page=353
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 35514,
    "next": "https://panelapp-aus.org/api/v1/genes/?format=api&page=354",
    "previous": "https://panelapp-aus.org/api/v1/genes/?format=api&page=352",
    "results": [
        {
            "gene_data": {
                "alias": [
                    "FLJ13096"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25784",
                "gene_name": "DDB1 and CUL4 associated factor 17",
                "omim_gene": [
                    "612515"
                ],
                "alias_name": [
                    "Woodhouse-Sakati syndrome"
                ],
                "gene_symbol": "DCAF17",
                "hgnc_symbol": "DCAF17",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:172290727-172341562",
                            "ensembl_id": "ENSG00000115827"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:171434217-171485052",
                            "ensembl_id": "ENSG00000115827"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-07-17"
            },
            "entity_type": "gene",
            "entity_name": "DCAF17",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33819414",
                "27240811",
                "20507343",
                "34630532",
                "31347785",
                "34590781",
                "29574468"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Woodhouse-Sakati syndrome, MIM# 241080",
                "Hypergonadotropic/ Hypogonadotropic Hypogonadism"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CSB",
                    "RAD26",
                    "ARMD5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3438",
                "gene_name": "ERCC excision repair 6, chromatin remodeling factor",
                "omim_gene": [
                    "609413"
                ],
                "alias_name": [
                    "Cockayne syndrome B protein"
                ],
                "gene_symbol": "ERCC6",
                "hgnc_symbol": "ERCC6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:50663414-50747584",
                            "ensembl_id": "ENSG00000225830"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:49455368-49539538",
                            "ensembl_id": "ENSG00000225830"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-06-30"
            },
            "entity_type": "gene",
            "entity_name": "ERCC6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "26218421",
                "33109206",
                "33538981",
                "39277148",
                "35975393"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure 11, MIM# 616946"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FAAP250"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23168",
                "gene_name": "Fanconi anemia complementation group M",
                "omim_gene": [
                    "609644"
                ],
                "alias_name": null,
                "gene_symbol": "FANCM",
                "hgnc_symbol": "FANCM",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:45605143-45670093",
                            "ensembl_id": "ENSG00000187790"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:45135940-45200890",
                            "ensembl_id": "ENSG00000187790"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-09-01"
            },
            "entity_type": "gene",
            "entity_name": "FANCM",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33036707",
                "29231814",
                "30075111",
                "29895858",
                "38927643"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure 15, MIM# 618096",
                "Spermatogenic failure 28, MIM# 618086"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "H2",
                    "H3",
                    "H4",
                    "H5",
                    "CEK",
                    "FLG",
                    "BFGFR",
                    "N-SAM",
                    "CD331"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3688",
                "gene_name": "fibroblast growth factor receptor 1",
                "omim_gene": [
                    "136350"
                ],
                "alias_name": [
                    "Pfeiffer syndrome"
                ],
                "gene_symbol": "FGFR1",
                "hgnc_symbol": "FGFR1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:38268656-38326352",
                            "ensembl_id": "ENSG00000077782"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:38411138-38468834",
                            "ensembl_id": "ENSG00000077782"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-02-25"
            },
            "entity_type": "gene",
            "entity_name": "FGFR1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "28008864",
                "26708526",
                "17154279",
                "21682876",
                "16764984"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 2 with or without anosmia\t, MIM#147950"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GGPPS1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4249",
                "gene_name": "geranylgeranyl diphosphate synthase 1",
                "omim_gene": [
                    "606982"
                ],
                "alias_name": null,
                "gene_symbol": "GGPS1",
                "hgnc_symbol": "GGPS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:235490665-235507847",
                            "ensembl_id": "ENSG00000152904"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:235327350-235344532",
                            "ensembl_id": "ENSG00000152904"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-08-26"
            },
            "entity_type": "gene",
            "entity_name": "GGPS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32399598",
                "32403198"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, MMIM#\t619518"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:5226",
                "gene_name": "heat shock transcription factor 2 binding protein",
                "omim_gene": [
                    "604554"
                ],
                "alias_name": [
                    "heat shock factor 2 binding protein"
                ],
                "gene_symbol": "HSF2BP",
                "hgnc_symbol": "HSF2BP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "21:44949072-45079374",
                            "ensembl_id": "ENSG00000160207"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "21:43529192-43659493",
                            "ensembl_id": "ENSG00000160207"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-08-26"
            },
            "entity_type": "gene",
            "entity_name": "HSF2BP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32845237",
                "35174157"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure 19, OMIM#619245"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HOT7T175",
                    "AXOR12"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4510",
                "gene_name": "KISS1 receptor",
                "omim_gene": [
                    "604161"
                ],
                "alias_name": null,
                "gene_symbol": "KISS1R",
                "hgnc_symbol": "KISS1R",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:917287-921015",
                            "ensembl_id": "ENSG00000116014"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:917287-921015",
                            "ensembl_id": "ENSG00000116014"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-02-15"
            },
            "entity_type": "gene",
            "entity_name": "KISS1R",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23349759",
                "22619348",
                "21193544",
                "17164310",
                "14573733",
                "27094476",
                "33819414"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 8 with or without anosmia, MIM# 614837"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Lhx7"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28838",
                "gene_name": "LIM homeobox 8",
                "omim_gene": [
                    "604425"
                ],
                "alias_name": null,
                "gene_symbol": "LHX8",
                "hgnc_symbol": "LHX8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:75594119-75627218",
                            "ensembl_id": "ENSG00000162624"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:75128434-75161533",
                            "ensembl_id": "ENSG00000162624"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-06-02"
            },
            "entity_type": "gene",
            "entity_name": "LHX8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "27603904",
                "34095689",
                "29329412",
                "36029299"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Inherited premature ovarian failure, MONDO:0019852, LHX8-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC35304",
                    "dJ329L24.3",
                    "FLJ20170"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21484",
                "gene_name": "minichromosome maintenance 9 homologous recombination repair factor",
                "omim_gene": [
                    "610098"
                ],
                "alias_name": null,
                "gene_symbol": "MCM9",
                "hgnc_symbol": "MCM9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:119134605-119256327",
                            "ensembl_id": "ENSG00000111877"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:118813442-118935162",
                            "ensembl_id": "ENSG00000111877"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-04-04"
            },
            "entity_type": "gene",
            "entity_name": "MCM9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "25480036",
                "26771056",
                "31042289"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Ovarian dysgenesis 4, MIM# 616185"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP-S22",
                    "GK002",
                    "C3orf5",
                    "GIBT"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14508",
                "gene_name": "mitochondrial ribosomal protein S22",
                "omim_gene": [
                    "605810"
                ],
                "alias_name": null,
                "gene_symbol": "MRPS22",
                "hgnc_symbol": "MRPS22",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:138724648-139076065",
                            "ensembl_id": "ENSG00000175110"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:139005806-139357223",
                            "ensembl_id": "ENSG00000175110"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-26"
            },
            "entity_type": "gene",
            "entity_name": "MRPS22",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29566152",
                "31042289"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Ovarian dysgenesis 7, MIM# 618117"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ATV",
                    "AT-V2",
                    "AT-V1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7652",
                "gene_name": "nibrin",
                "omim_gene": [
                    "602667"
                ],
                "alias_name": null,
                "gene_symbol": "NBN",
                "hgnc_symbol": "NBN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:90945564-91015456",
                            "ensembl_id": "ENSG00000104320"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:89933336-90003228",
                            "ensembl_id": "ENSG00000104320"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-06-02"
            },
            "entity_type": "gene",
            "entity_name": "NBN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "19105185",
                "29706645",
                "31729086",
                "34794894",
                "20444919"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Nijmegen breakage syndrome, MIM# 251260"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7882",
                "gene_name": "notch 2",
                "omim_gene": [
                    "600275"
                ],
                "alias_name": null,
                "gene_symbol": "NOTCH2",
                "hgnc_symbol": "NOTCH2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:120454176-120612240",
                            "ensembl_id": "ENSG00000134250"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:119911553-120069626",
                            "ensembl_id": "ENSG00000134250"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-11-10"
            },
            "entity_type": "gene",
            "entity_name": "NOTCH2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32312275",
                "30304577",
                "28505269",
                "28283672"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Inherited primary ovarian failure, MONDO:0019852, NOTCH2-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NUP84"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29914",
                "gene_name": "nucleoporin 107",
                "omim_gene": [
                    "607617"
                ],
                "alias_name": null,
                "gene_symbol": "NUP107",
                "hgnc_symbol": "NUP107",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:69080514-69136785",
                            "ensembl_id": "ENSG00000111581"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:68686734-68745809",
                            "ensembl_id": "ENSG00000111581"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-19"
            },
            "entity_type": "gene",
            "entity_name": "NUP107",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "26485283",
                "34707299",
                "29363275"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Ovarian dysgenesis 6, MIM# 618078"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NTE",
                    "sws",
                    "iPLA2delta",
                    "SPG39"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16268",
                "gene_name": "patatin like phospholipase domain containing 6",
                "omim_gene": [
                    "603197"
                ],
                "alias_name": [
                    "neuropathy target esterase"
                ],
                "gene_symbol": "PNPLA6",
                "hgnc_symbol": "PNPLA6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:7598890-7626650",
                            "ensembl_id": "ENSG00000032444"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:7534004-7561764",
                            "ensembl_id": "ENSG00000032444"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-07-05"
            },
            "entity_type": "gene",
            "entity_name": "PNPLA6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "27866050",
                "24790214",
                "25267340",
                "25033069",
                "24355708",
                "33141049"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Boucher-Neuhauser syndrome, MIM# 215470"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "RPC1",
                    "RPC155",
                    "hRPC155"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30074",
                "gene_name": "RNA polymerase III subunit A",
                "omim_gene": [
                    "614258"
                ],
                "alias_name": null,
                "gene_symbol": "POLR3A",
                "hgnc_symbol": "POLR3A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:79734907-79789303",
                            "ensembl_id": "ENSG00000148606"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:77969251-78029545",
                            "ensembl_id": "ENSG00000148606"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-09-16"
            },
            "entity_type": "gene",
            "entity_name": "POLR3A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23694757",
                "21855841",
                "30414627",
                "34611991"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, MIM# 607694"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CYPOR",
                    "FLJ26468"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9208",
                "gene_name": "cytochrome p450 oxidoreductase",
                "omim_gene": [
                    "124015"
                ],
                "alias_name": null,
                "gene_symbol": "POR",
                "hgnc_symbol": "POR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:75528518-75616173",
                            "ensembl_id": "ENSG00000127948"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:75899200-75986855",
                            "ensembl_id": "ENSG00000127948"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-06-30"
            },
            "entity_type": "gene",
            "entity_name": "POR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32725309",
                "32242900"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Disordered steroidogenesis due to cytochrome P450 oxidoreductase,\tMIM# 613571"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CT42"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11738",
                "gene_name": "testis expressed 15, meiosis and synapsis associated",
                "omim_gene": [
                    "605795"
                ],
                "alias_name": [
                    "cancer/testis antigen 42"
                ],
                "gene_symbol": "TEX15",
                "hgnc_symbol": "TEX15",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:30689060-30748122",
                            "ensembl_id": "ENSG00000133863"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:30831544-30890606",
                            "ensembl_id": "ENSG00000133863"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-06-16"
            },
            "entity_type": "gene",
            "entity_name": "TEX15",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "26199321",
                "28355598",
                "28303806"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "spermatogenic failure MONDO:0004983"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "MGC33887"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28514",
                "gene_name": "centrosomal protein 112",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CEP112",
                "hgnc_symbol": "CEP112",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:63631656-64188202",
                            "ensembl_id": "ENSG00000154240"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:65635538-66192084",
                            "ensembl_id": "ENSG00000154240"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-05-06"
            },
            "entity_type": "gene",
            "entity_name": "CEP112",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "39349455",
                "31654588"
            ],
            "evidence": [
                "Literature",
                "Expert Review Green",
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 44, MIM#619044",
                "Acephalic spermatozoa",
                "infertility"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32818"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19007",
                "gene_name": "homeodomain interacting protein kinase 4",
                "omim_gene": [
                    "611712"
                ],
                "alias_name": null,
                "gene_symbol": "HIPK4",
                "hgnc_symbol": "HIPK4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:40885178-40896094",
                            "ensembl_id": "ENSG00000160396"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:40379271-40390187",
                            "ensembl_id": "ENSG00000160396"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-01-29"
            },
            "entity_type": "gene",
            "entity_name": "HIPK4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "10.64898/2026.03.04.26346694",
                "35931115"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "Infertility disorder, MONDO:0005047, HIPK4-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0436"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30228",
                "gene_name": "prolyl endopeptidase-like",
                "omim_gene": [
                    "609557"
                ],
                "alias_name": null,
                "gene_symbol": "PREPL",
                "hgnc_symbol": "PREPL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:44543420-44589001",
                            "ensembl_id": "ENSG00000138078"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:44316281-44361862",
                            "ensembl_id": "ENSG00000138078"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-02-25"
            },
            "entity_type": "gene",
            "entity_name": "PREPL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34794894",
                "28726805",
                "30924587",
                "32218803"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Myasthenic syndrome, congenital, 22, MIM#\t616224",
                "Hypergonadotropic hypogonadism"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PK2",
                    "BV8",
                    "MIT1",
                    "KAL4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18455",
                "gene_name": "prokineticin 2",
                "omim_gene": [
                    "607002"
                ],
                "alias_name": [
                    "protein Bv8 homolog"
                ],
                "gene_symbol": "PROK2",
                "hgnc_symbol": "PROK2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:71820807-71834357",
                            "ensembl_id": "ENSG00000163421"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:71771656-71785206",
                            "ensembl_id": "ENSG00000163421"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-07-22"
            },
            "entity_type": "gene",
            "entity_name": "PROK2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23341491",
                "18559922",
                "17959774",
                "17054399",
                "31200363",
                "33819414"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 4 with or without anosmia, MIM# 610628"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRIAD3",
                    "UBCE7IP1",
                    "ZIN"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21698",
                "gene_name": "ring finger protein 216",
                "omim_gene": [
                    "609948"
                ],
                "alias_name": null,
                "gene_symbol": "RNF216",
                "hgnc_symbol": "RNF216",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:5659678-5821370",
                            "ensembl_id": "ENSG00000011275"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:5620047-5781739",
                            "ensembl_id": "ENSG00000011275"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-20"
            },
            "entity_type": "gene",
            "entity_name": "RNF216",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "31200363",
                "25841028",
                "39444518",
                "38050071"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Cerebellar ataxia and hypogonadotropic hypogonadism, MIM# 212840"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SEMA1",
                    "SemD",
                    "coll-1",
                    "Hsema-I"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10723",
                "gene_name": "semaphorin 3A",
                "omim_gene": [
                    "603961"
                ],
                "alias_name": [
                    "sema III"
                ],
                "gene_symbol": "SEMA3A",
                "hgnc_symbol": "SEMA3A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:83585093-84122040",
                            "ensembl_id": "ENSG00000075213"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:83955777-84492724",
                            "ensembl_id": "ENSG00000075213"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-06-25"
            },
            "entity_type": "gene",
            "entity_name": "SEMA3A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "22416012",
                "22927827",
                "32060892",
                "31200363",
                "33819414"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 16 with or without anosmia, MIM# 614897"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ZNEUROK1",
                    "NKB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11521",
                "gene_name": "tachykinin 3",
                "omim_gene": [
                    "162330"
                ],
                "alias_name": [
                    "preprotachykinin-B"
                ],
                "gene_symbol": "TAC3",
                "hgnc_symbol": "TAC3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:57403784-57422667",
                            "ensembl_id": "ENSG00000166863"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:57010000-57028883",
                            "ensembl_id": "ENSG00000166863"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "TAC3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "20332248",
                "20194706",
                "34403359",
                "19079066"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 10 with or without anosmia, MIM# 614839"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NK3R"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11528",
                "gene_name": "tachykinin receptor 3",
                "omim_gene": [
                    "162332"
                ],
                "alias_name": [
                    "neurokinin beta receptor"
                ],
                "gene_symbol": "TACR3",
                "hgnc_symbol": "TACR3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:104507188-104640973",
                            "ensembl_id": "ENSG00000169836"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:103586031-103719816",
                            "ensembl_id": "ENSG00000169836"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-11-28"
            },
            "entity_type": "gene",
            "entity_name": "TACR3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "22031817",
                "20332248",
                "20194706",
                "20395662",
                "19755480",
                "28915117",
                "19079066"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 11 with or without anosmia, MIM# 614840"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "dJ62D2.1",
                    "NO145"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21537",
                "gene_name": "synaptonemal complex protein 2 like",
                "omim_gene": [
                    "616799"
                ],
                "alias_name": null,
                "gene_symbol": "SYCP2L",
                "hgnc_symbol": "SYCP2L",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:10748027-10979553",
                            "ensembl_id": "ENSG00000153157"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:10886831-10979320",
                            "ensembl_id": "ENSG00000153157"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-07-02"
            },
            "entity_type": "gene",
            "entity_name": "SYCP2L",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32303603",
                "38521400"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure 24, MIM# 620840"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "p51",
                    "SHFM4",
                    "EEC3",
                    "p63",
                    "p73L",
                    "OFC8",
                    "KET",
                    "p73H",
                    "NBP",
                    "p53CP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15979",
                "gene_name": "tumor protein p63",
                "omim_gene": [
                    "603273"
                ],
                "alias_name": null,
                "gene_symbol": "TP63",
                "hgnc_symbol": "TP63",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:189349205-189615068",
                            "ensembl_id": "ENSG00000073282"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:189631416-189897279",
                            "ensembl_id": "ENSG00000073282"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-04-18"
            },
            "entity_type": "gene",
            "entity_name": "TP63",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30924587",
                "35801529",
                "36856110",
                "27798044"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure 21, MIM# 620311"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PEO",
                    "PEO1",
                    "TWINKLE",
                    "FLJ21832",
                    "TWINL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1160",
                "gene_name": "twinkle mtDNA helicase",
                "omim_gene": [
                    "606075"
                ],
                "alias_name": [
                    "T7 helicase-related protein with intramitochondrial nucleoid localization"
                ],
                "gene_symbol": "TWNK",
                "hgnc_symbol": "TWNK",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:102747124-102754158",
                            "ensembl_id": "ENSG00000107815"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:100987367-100994401",
                            "ensembl_id": "ENSG00000107815"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2016-10-11"
            },
            "entity_type": "gene",
            "entity_name": "TWNK",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "28178980",
                "26970254",
                "25355836",
                "25355836",
                "32281099",
                "31852434",
                "31455392"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Perrault syndrome 5, MIM# 616138"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1351",
                    "FLJ10506",
                    "WDR15",
                    "HH14",
                    "DR11",
                    "SRI1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13831",
                "gene_name": "WD repeat domain 11",
                "omim_gene": [
                    "606417"
                ],
                "alias_name": [
                    "sensitization to ricin complex subunit 1"
                ],
                "gene_symbol": "WDR11",
                "hgnc_symbol": "WDR11",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:122610687-122669036",
                            "ensembl_id": "ENSG00000120008"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:120851175-120909524",
                            "ensembl_id": "ENSG00000120008"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-01-06"
            },
            "entity_type": "gene",
            "entity_name": "WDR11",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "20887964, 37988663",
                "36130823",
                "35722485",
                "32982993",
                "29263200"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 14 with or without anosmia, MIM# 614858"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KALIG-1",
                    "WFDC19"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6211",
                "gene_name": "anosmin 1",
                "omim_gene": [
                    "300836"
                ],
                "alias_name": [
                    "anosmin-1",
                    "WAP four-disulfide core domain 19",
                    "Adhesion molecule-like, X-linked",
                    "Kallmann syndrome interval gene 1"
                ],
                "gene_symbol": "ANOS1",
                "hgnc_symbol": "ANOS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:8496915-8700227",
                            "ensembl_id": "ENSG00000011201"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:8528874-8732186",
                            "ensembl_id": "ENSG00000011201"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-04-10"
            },
            "entity_type": "gene",
            "entity_name": "ANOS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40508017",
                "40262549",
                "40258767",
                "40101754",
                "16882753"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), MIM# 308700"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BS",
                    "RECQL3",
                    "RECQ2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1058",
                "gene_name": "Bloom syndrome RecQ like helicase",
                "omim_gene": [
                    "604610"
                ],
                "alias_name": null,
                "gene_symbol": "BLM",
                "hgnc_symbol": "BLM",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:91260558-91358859",
                            "ensembl_id": "ENSG00000197299"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:90717327-90816165",
                            "ensembl_id": "ENSG00000197299"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-11-06"
            },
            "entity_type": "gene",
            "entity_name": "BLM",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34794894",
                "29056561",
                "28846287"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Bloom syndrome, MIM# 210900"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC3130"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28460",
                "gene_name": "chromosome 17 open reading frame 53",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "C17orf53",
                "hgnc_symbol": "C17orf53",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:42219274-42239844",
                            "ensembl_id": "ENSG00000125319"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:44141906-44162476",
                            "ensembl_id": "ENSG00000125319"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-12-15"
            },
            "entity_type": "gene",
            "entity_name": "C17orf53",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34707299",
                "38105698",
                "36099812",
                "31467087"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Ovarian dysgenesis 11, MIM# 620897"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HSP78",
                    "SKD3",
                    "FLJ13152",
                    "ANKCLB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:30664",
                "gene_name": "ClpB homolog, mitochondrial AAA ATPase chaperonin",
                "omim_gene": [
                    "616254"
                ],
                "alias_name": [
                    "suppressor of potassium transport defect 3",
                    "ankyrin-repeat containing bacterial clp fusion"
                ],
                "gene_symbol": "CLPB",
                "hgnc_symbol": "CLPB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:72003469-72145692",
                            "ensembl_id": "ENSG00000162129"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:72292425-72434680",
                            "ensembl_id": "ENSG00000162129"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-10-04"
            },
            "entity_type": "gene",
            "entity_name": "CLPB",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36074910"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropaenia, MIM# 616271",
                "Primary ovarian insufficiency"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRPS29",
                    "DAP-3",
                    "MRP-S29",
                    "bMRP-10",
                    "MGC126058",
                    "MGC126059",
                    "DKFZp686G12159"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2673",
                "gene_name": "death associated protein 3",
                "omim_gene": [
                    "602074"
                ],
                "alias_name": [
                    "mitochondrial 28S ribosomal protein S29"
                ],
                "gene_symbol": "DAP3",
                "hgnc_symbol": "DAP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:155657751-155708801",
                            "ensembl_id": "ENSG00000132676"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:155687960-155739010",
                            "ensembl_id": "ENSG00000132676"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-05-14"
            },
            "entity_type": "gene",
            "entity_name": "DAP3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "39701103"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Perrault syndrome 7, MIM# 621101"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1325",
                "gene_name": "complement component 4 binding protein alpha",
                "omim_gene": [
                    "120830"
                ],
                "alias_name": null,
                "gene_symbol": "C4BPA",
                "hgnc_symbol": "C4BPA",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:207277607-207318317",
                            "ensembl_id": "ENSG00000123838"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:207104262-207144972",
                            "ensembl_id": "ENSG00000123838"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "C4BPA",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23508668"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "recurrent pregnancy loss susceptibility MONDO:0000144, C4BPA-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FKBP59",
                    "FKBP52"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3720",
                "gene_name": "FK506 binding protein 4",
                "omim_gene": [
                    "600611"
                ],
                "alias_name": null,
                "gene_symbol": "FKBP4",
                "hgnc_symbol": "FKBP4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:2904119-2914576",
                            "ensembl_id": "ENSG00000004478"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:2794953-2805423",
                            "ensembl_id": "ENSG00000004478"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-09-14"
            },
            "entity_type": "gene",
            "entity_name": "FKBP4",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "31504499"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Recurrent pregnancy loss susceptibility, MONDO:0000144, FKBP4-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7436",
                "gene_name": "methylenetetrahydrofolate reductase",
                "omim_gene": [
                    "607093"
                ],
                "alias_name": null,
                "gene_symbol": "MTHFR",
                "hgnc_symbol": "MTHFR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:11845780-11866977",
                            "ensembl_id": "ENSG00000177000"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:11785723-11806920",
                            "ensembl_id": "ENSG00000177000"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-07-15"
            },
            "entity_type": "gene",
            "entity_name": "MTHFR",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "37260775",
                "39534907",
                "38322638"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Homocystinuria due to MTHFR deficiency MIM#236250",
                "Recurrent pregnancy loss susceptibility"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CAPS1",
                    "MGC126562"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1487",
                "gene_name": "calcyphosine",
                "omim_gene": [
                    "114212"
                ],
                "alias_name": [
                    "calcyphosine 1",
                    "thyroid protein p24"
                ],
                "gene_symbol": "CAPS",
                "hgnc_symbol": "CAPS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:5911718-5915888",
                            "ensembl_id": "ENSG00000105519"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:5911707-5915877",
                            "ensembl_id": "ENSG00000105519"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-05-31"
            },
            "entity_type": "gene",
            "entity_name": "CAPS",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30339840"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Recurrent pregnancy loss, susceptibility to, MONDO:0000144, CAPS-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FAP221",
                    "PCDP1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:33720",
                "gene_name": "cilia and flagella associated protein 221",
                "omim_gene": null,
                "alias_name": [
                    "flagellar associated protein 221 homolog (Chlamydomonas)",
                    "primary ciliary dyskinesia 1 homolog (mouse)"
                ],
                "gene_symbol": "CFAP221",
                "hgnc_symbol": "CFAP221",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:120302008-120419827",
                            "ensembl_id": "ENSG00000163075"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:119544432-119662251",
                            "ensembl_id": "ENSG00000163075"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2014-07-03"
            },
            "entity_type": "gene",
            "entity_name": "CFAP221",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "31636325",
                "39362668",
                "40250778",
                "38960684",
                "40272718"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Ciliary dyskinesia, primary, 55, MIM# 279000"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "CT113"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11737",
                "gene_name": "testis expressed 14, intercellular bridge forming factor",
                "omim_gene": [
                    "605792"
                ],
                "alias_name": [
                    "cancer/testis antigen 113"
                ],
                "gene_symbol": "TEX14",
                "hgnc_symbol": "TEX14",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:56634039-56769416",
                            "ensembl_id": "ENSG00000121101"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:58556678-58692055",
                            "ensembl_id": "ENSG00000121101"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-06-16"
            },
            "entity_type": "gene",
            "entity_name": "TEX14",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "16549803",
                "40492599",
                "28206990",
                "29790874",
                "36017582"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure MONDO:0004983, TEX14-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:161",
                "gene_name": "actin like 7A",
                "omim_gene": [
                    "604303"
                ],
                "alias_name": null,
                "gene_symbol": "ACTL7A",
                "hgnc_symbol": "ACTL7A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:111624603-111626035",
                            "ensembl_id": "ENSG00000187003"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:108862266-108863759",
                            "ensembl_id": "ENSG00000187003"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-07-14"
            },
            "entity_type": "gene",
            "entity_name": "ACTL7A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32923619",
                "34727571",
                "36593593",
                "37004249",
                "37991128",
                "36574082",
                "35921706"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 86, #MIM 620499"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC33407"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28494",
                "gene_name": "actin like 9",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "ACTL9",
                "hgnc_symbol": "ACTL9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:8807751-8809172",
                            "ensembl_id": "ENSG00000181786"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:8697397-8698822",
                            "ensembl_id": "ENSG00000181786"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-05-15"
            },
            "entity_type": "gene",
            "entity_name": "ACTL9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33626338",
                "38963606"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 53, MIM# 619258"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29350",
                "gene_name": "IQ motif containing N",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "KIAA1683",
                "hgnc_symbol": "IQCN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:18367908-18385319",
                            "ensembl_id": "ENSG00000130518"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:18257097-18274509",
                            "ensembl_id": "ENSG00000130518"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2017-10-24"
            },
            "entity_type": "gene",
            "entity_name": "KIAA1683",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36321563",
                "39872118",
                "37140151",
                "37184908",
                "40437858"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 78, #MIM 620170"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KCa5.1",
                    "Slo3",
                    "KCNMC1",
                    "Kcnma3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18867",
                "gene_name": "potassium calcium-activated channel subfamily U member 1",
                "omim_gene": [
                    "615215"
                ],
                "alias_name": null,
                "gene_symbol": "KCNU1",
                "hgnc_symbol": "KCNU1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:36641842-36793646",
                            "ensembl_id": "ENSG00000215262"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:36784324-36936128",
                            "ensembl_id": "ENSG00000215262"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-07-10"
            },
            "entity_type": "gene",
            "entity_name": "KCNU1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34980136",
                "35551387",
                "20138882",
                "21427226",
                "25271166",
                "35551387"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 79, #MIM 620196"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "APG4-D"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20789",
                "gene_name": "autophagy related 4D cysteine peptidase",
                "omim_gene": [
                    "611340"
                ],
                "alias_name": null,
                "gene_symbol": "ATG4D",
                "hgnc_symbol": "ATG4D",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:10654571-10664094",
                            "ensembl_id": "ENSG00000130734"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:10543895-10553418",
                            "ensembl_id": "ENSG00000130734"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-09-11"
            },
            "entity_type": "gene",
            "entity_name": "ATG4D",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33988247"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 101, MIM#\t621269"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ33071",
                    "HIT-4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26573",
                "gene_name": "zinc finger protein 597",
                "omim_gene": [
                    "614685"
                ],
                "alias_name": null,
                "gene_symbol": "ZNF597",
                "hgnc_symbol": "ZNF597",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:3486104-3493542",
                            "ensembl_id": "ENSG00000167981"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:3432422-3443542",
                            "ensembl_id": "ENSG00000167981"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-01"
            },
            "entity_type": "gene",
            "entity_name": "ZNF597",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "28157578",
                "28157578",
                "2576657"
            ],
            "evidence": [
                "Expert Review Red",
                "Research",
                "Literature"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Other",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ43808"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2941",
                "gene_name": "dynein axonemal heavy chain 10",
                "omim_gene": [
                    "605884"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH10",
                "hgnc_symbol": "DNAH10",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:124247042-124420753",
                            "ensembl_id": "ENSG00000197653"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:123762188-123936206",
                            "ensembl_id": "ENSG00000197653"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-07-31"
            },
            "entity_type": "gene",
            "entity_name": "DNAH10",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34237282"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Spermatogenic failure 56, MIM# 619515"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32752",
                    "FLJ46184",
                    "FLJ35709",
                    "DKFZp686J0796"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26532",
                "gene_name": "dynein heavy chain domain 1",
                "omim_gene": [
                    "617277"
                ],
                "alias_name": null,
                "gene_symbol": "DNHD1",
                "hgnc_symbol": "DNHD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:6518490-6614988",
                            "ensembl_id": "ENSG00000179532"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:6497260-6593758",
                            "ensembl_id": "ENSG00000179532"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-11-28"
            },
            "entity_type": "gene",
            "entity_name": "DNHD1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34932939"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 65, MIM# 619712"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17196",
                "gene_name": "DNA helicase B",
                "omim_gene": [
                    "614539"
                ],
                "alias_name": null,
                "gene_symbol": "HELB",
                "hgnc_symbol": "HELB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:66696325-66737423",
                            "ensembl_id": "ENSG00000127311"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:66302545-66347645",
                            "ensembl_id": "ENSG00000127311"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-25"
            },
            "entity_type": "gene",
            "entity_name": "HELB",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "41212051"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "Premature ovarian failure, MONDO:0019852, HELB-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1503",
                    "FLJ46675"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2948",
                "gene_name": "dynein axonemal heavy chain 2",
                "omim_gene": [
                    "603333"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH2",
                "hgnc_symbol": "DNAH2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:7620672-7737062",
                            "ensembl_id": "ENSG00000183914"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:7717354-7833744",
                            "ensembl_id": "ENSG00000183914"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-15"
            },
            "entity_type": "gene",
            "entity_name": "DNAH2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30811583",
                "32732226",
                "40592014"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 45, MIM# 619094"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "Dnahc6",
                    "HL-2",
                    "FLJ37357"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2951",
                "gene_name": "dynein axonemal heavy chain 6",
                "omim_gene": [
                    "603336"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH6",
                "hgnc_symbol": "DNAH6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:84743579-85046713",
                            "ensembl_id": "ENSG00000115423"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:84516455-84819589",
                            "ensembl_id": "ENSG00000115423"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-15"
            },
            "entity_type": "gene",
            "entity_name": "DNAH6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "37594300",
                "39192248",
                "37424858",
                "31676830",
                "29356036",
                "40592014"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, DNAH6-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0008",
                    "DLG1",
                    "HURP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16864",
                "gene_name": "DLG associated protein 5",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "DLGAP5",
                "hgnc_symbol": "DLGAP5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:55614830-55658396",
                            "ensembl_id": "ENSG00000126787"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:55148112-55191678",
                            "ensembl_id": "ENSG00000126787"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-05-30"
            },
            "entity_type": "gene",
            "entity_name": "DLGAP5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40796344"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Infertility disorder, MONDO:0005047, DLGAP5-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "MGC104706"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28078",
                "gene_name": "coiled-coil domain containing 189",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CCDC189",
                "hgnc_symbol": "CCDC189",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:30768744-30774031",
                            "ensembl_id": "ENSG00000196118"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:30757423-30762710",
                            "ensembl_id": "ENSG00000196118"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-10-06"
            },
            "entity_type": "gene",
            "entity_name": "CCDC189",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40759592"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, CCDC189-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "ECAT8",
                    "FLJ13072"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25044",
                "gene_name": "tudor domain containing 12",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "TDRD12",
                "hgnc_symbol": "TDRD12",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:33210659-33320483",
                            "ensembl_id": "ENSG00000173809"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:32719753-32829580",
                            "ensembl_id": "ENSG00000173809"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-11-15"
            },
            "entity_type": "gene",
            "entity_name": "TDRD12",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40750267"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, TDRD12-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "MGC35154"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28563",
                "gene_name": "testis expressed 44",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "TEX44",
                "hgnc_symbol": "TEX44",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:232457575-232458994",
                            "ensembl_id": "ENSG00000177673"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:231592901-231594283",
                            "ensembl_id": "ENSG00000177673"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2016-11-03"
            },
            "entity_type": "gene",
            "entity_name": "TEX44",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40849303"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, TEX44-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZp434N0820",
                    "FLJ36164",
                    "NET54"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20122",
                "gene_name": "tudor domain containing 9",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "TDRD9",
                "hgnc_symbol": "TDRD9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:104394799-104519004",
                            "ensembl_id": "ENSG00000156414"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:103928462-104052667",
                            "ensembl_id": "ENSG00000156414"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-04-02"
            },
            "entity_type": "gene",
            "entity_name": "TDRD9",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "28536242",
                "40645105",
                "20059948",
                "39267058",
                "39174853",
                "35172124"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "spermatogenic failure MONDO:0004983"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ40162"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:24753",
                "gene_name": "potassium channel tetramerization domain containing 19",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "KCTD19",
                "hgnc_symbol": "KCTD19",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:67323331-67360666",
                            "ensembl_id": "ENSG00000168676"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:67289428-67326763",
                            "ensembl_id": "ENSG00000168676"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-02-08"
            },
            "entity_type": "gene",
            "entity_name": "KCTD19",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "37192818",
                "37485353",
                "39318590",
                "40410542",
                "41221840"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Infertility disorder, MONDO:0005047, KCTD19-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "Figlb",
                    "E2BP-1",
                    "CHA",
                    "bHLHe82"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11646",
                "gene_name": "transcription factor like 5",
                "omim_gene": [
                    "604745"
                ],
                "alias_name": [
                    "HPV-16 E2 binding protein 1"
                ],
                "gene_symbol": "TCFL5",
                "hgnc_symbol": "TCFL5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:61472467-61493115",
                            "ensembl_id": "ENSG00000101190"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:62841115-62861763",
                            "ensembl_id": "ENSG00000101190"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-11-19"
            },
            "entity_type": "gene",
            "entity_name": "TCFL5",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 40711600"
            ],
            "evidence": [
                "Literature"
            ],
            "phenotypes": [
                "Oligoasthenoteratozoospermia MONDO:0850098"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "TUBL2",
                    "CT65"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12424",
                "gene_name": "tubby like protein 2",
                "omim_gene": [
                    "602309"
                ],
                "alias_name": [
                    "cancer/testis antigen 65"
                ],
                "gene_symbol": "TULP2",
                "hgnc_symbol": "TULP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:49384222-49401990",
                            "ensembl_id": "ENSG00000104804"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:48880965-48898733",
                            "ensembl_id": "ENSG00000104804"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-01-06"
            },
            "entity_type": "gene",
            "entity_name": "TULP2",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35619658: 33763418",
                "40613306"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "male infertility MONDO:0005372"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ38159"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26762",
                "gene_name": "coiled-coil domain containing 89",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CCDC89",
                "hgnc_symbol": "CCDC89",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:85394893-85397320",
                            "ensembl_id": "ENSG00000179071"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:85684866-85686277",
                            "ensembl_id": "ENSG00000179071"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-03-16"
            },
            "entity_type": "gene",
            "entity_name": "CCDC89",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40591933"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "spermatogenic failure MONDO:0004983"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "P15-2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18151",
                "gene_name": "nuclear transport factor 2 like export factor 2",
                "omim_gene": [
                    "300320"
                ],
                "alias_name": null,
                "gene_symbol": "NXT2",
                "hgnc_symbol": "NXT2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:108779010-108787919",
                            "ensembl_id": "ENSG00000101888"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:109535781-109544690",
                            "ensembl_id": "ENSG00000101888"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-12-02"
            },
            "entity_type": "gene",
            "entity_name": "NXT2",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 40624043",
                "35013161"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, NXT2-related"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32940"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26564",
                "gene_name": "axonemal dynein light chain domain containing 1",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "AXDND1",
                "hgnc_symbol": "AXDND1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:179334855-179523870",
                            "ensembl_id": "ENSG00000162779"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:179365720-179554735",
                            "ensembl_id": "ENSG00000162779"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2011-02-18"
            },
            "entity_type": "gene",
            "entity_name": "AXDND1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "40457935"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, AXDND1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ25692"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26368",
                "gene_name": "minichromosome maintenance domain containing 2",
                "omim_gene": [
                    "617545"
                ],
                "alias_name": null,
                "gene_symbol": "MCMDC2",
                "hgnc_symbol": "MCMDC2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:67782984-67834283",
                            "ensembl_id": "ENSG00000178460"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:66870749-66922048",
                            "ensembl_id": "ENSG00000178460"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-04-13"
            },
            "entity_type": "gene",
            "entity_name": "MCMDC2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 40897906",
                "35172124",
                "39789727",
                "36732629"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Azoospermia, MONDO:0100459, MCMDC2-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ36601",
                    "RP13-11B7.1",
                    "MGC34831"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26708",
                "gene_name": "cilia and flagella associated protein 47",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CFAP47",
                "hgnc_symbol": "CFAP47",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:35937851-36008269",
                            "ensembl_id": "ENSG00000165164"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:35919734-36385319",
                            "ensembl_id": "ENSG00000165164"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-02-03"
            },
            "entity_type": "gene",
            "entity_name": "CFAP47",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "33472045",
                "39698362"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, X-linked, 3, MIM# 301059"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NFBD1",
                    "KIAA0170",
                    "Em:AB023051.5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21163",
                "gene_name": "mediator of DNA damage checkpoint 1",
                "omim_gene": [
                    "607593"
                ],
                "alias_name": null,
                "gene_symbol": "MDC1",
                "hgnc_symbol": "MDC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:30667584-30685666",
                            "ensembl_id": "ENSG00000137337"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:30699807-30717889",
                            "ensembl_id": "ENSG00000137337"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-05-21"
            },
            "entity_type": "gene",
            "entity_name": "MDC1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 40954969, 34089056"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Oligoasthenoteratozoospermia, MONDO:0850098, MDC1-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:51899",
                "gene_name": "coiled-coil domain containing 188",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CCDC188",
                "hgnc_symbol": "CCDC188",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "22:20135950-20138399",
                            "ensembl_id": "ENSG00000234409"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "22:20148427-20151065",
                            "ensembl_id": "ENSG00000234409"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-09-17"
            },
            "entity_type": "gene",
            "entity_name": "CCDC188",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "41004021"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Male infertility due to acephalic spermatozoa, MONDO:0035153"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ13265",
                    "CCNP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25805",
                "gene_name": "cyclin N-terminal domain containing 2",
                "omim_gene": null,
                "alias_name": [
                    "cyclin P"
                ],
                "gene_symbol": "CNTD2",
                "hgnc_symbol": "CNTD2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:40728115-40732597",
                            "ensembl_id": "ENSG00000105219"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:40222208-40226690",
                            "ensembl_id": "ENSG00000105219"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-03-31"
            },
            "entity_type": "gene",
            "entity_name": "CNTD2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "41005306"
            ],
            "evidence": [
                "Expert Review Green",
                "Other"
            ],
            "phenotypes": [
                "Oocyte/zygote/embryo maturation arrest MONDO:0014769"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SWS1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26993",
                "gene_name": "zinc finger SWIM-type containing 7",
                "omim_gene": [
                    "614535"
                ],
                "alias_name": [
                    "SWIM domain containing Srs2 interacting protein 1"
                ],
                "gene_symbol": "ZSWIM7",
                "hgnc_symbol": "ZSWIM7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:15879874-15903031",
                            "ensembl_id": "ENSG00000214941"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:15976560-15999717",
                            "ensembl_id": "ENSG00000214941"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-03-27"
            },
            "entity_type": "gene",
            "entity_name": "ZSWIM7",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32719396, 33713115, 40991243, 34402903"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 71 MONDO:0030787",
                "Ovarian dysgenesis 10  MONDO:0030736"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OST",
                    "KIAA0115",
                    "OST48",
                    "WBP1",
                    "GATD6"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2728",
                "gene_name": "dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit",
                "omim_gene": [
                    "602202"
                ],
                "alias_name": [
                    "oligosaccharyltransferase subunit 48",
                    "advanced glycation end-product receptor 1"
                ],
                "gene_symbol": "DDOST",
                "hgnc_symbol": "DDOST",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:20978270-20988000",
                            "ensembl_id": "ENSG00000244038"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:20651767-20661544",
                            "ensembl_id": "ENSG00000244038"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-12-23"
            },
            "entity_type": "gene",
            "entity_name": "DDOST",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "41005306"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "inherited oocyte maturation defect MONDO:0014769"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ34780"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21675",
                "gene_name": "fibrous sheath interacting protein 2",
                "omim_gene": [
                    "615796"
                ],
                "alias_name": null,
                "gene_symbol": "FSIP2",
                "hgnc_symbol": "FSIP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:186603355-186698017",
                            "ensembl_id": "ENSG00000188738"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:185738895-185833290",
                            "ensembl_id": "ENSG00000188738"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-06-21"
            },
            "entity_type": "gene",
            "entity_name": "FSIP2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30137358",
                "40968718",
                "36632462",
                "33631238"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 34, MIM#618153"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ31633"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6058",
                "gene_name": "inner centromere protein",
                "omim_gene": [
                    "604411"
                ],
                "alias_name": null,
                "gene_symbol": "INCENP",
                "hgnc_symbol": "INCENP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:61891445-61920635",
                            "ensembl_id": "ENSG00000149503"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:62123973-62153163",
                            "ensembl_id": "ENSG00000149503"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1988-06-09"
            },
            "entity_type": "gene",
            "entity_name": "INCENP",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "41005306"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Oocyte/zygote/embryo maturation arrest MONDO:0014769, INCENP-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8807",
                "gene_name": "pyruvate dehydrogenase E1 alpha 2 subunit",
                "omim_gene": [
                    "179061"
                ],
                "alias_name": null,
                "gene_symbol": "PDHA2",
                "hgnc_symbol": "PDHA2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:96761239-96762625",
                            "ensembl_id": "ENSG00000163114"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:95840019-95841474",
                            "ensembl_id": "ENSG00000163114"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-07-11"
            },
            "entity_type": "gene",
            "entity_name": "PDHA2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29581481",
                "35172124"
            ],
            "evidence": [
                "Expert Review Red",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 70, MIM# 619828"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GREAT",
                    "GPR106",
                    "INSL3R",
                    "RXFPR2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17318",
                "gene_name": "relaxin/insulin like family peptide receptor 2",
                "omim_gene": [
                    "606655"
                ],
                "alias_name": null,
                "gene_symbol": "RXFP2",
                "hgnc_symbol": "RXFP2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "13:32313674-32377009",
                            "ensembl_id": "ENSG00000133105"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "13:31739542-31803388",
                            "ensembl_id": "ENSG00000133105"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-09"
            },
            "entity_type": "gene",
            "entity_name": "RXFP2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "39222519",
                "37208861",
                "38430325"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, RXFP2-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14468",
                "gene_name": "solute carrier family 26 member 8",
                "omim_gene": [
                    "608480"
                ],
                "alias_name": null,
                "gene_symbol": "SLC26A8",
                "hgnc_symbol": "SLC26A8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:35911291-35992645",
                            "ensembl_id": "ENSG00000112053"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:35943514-36024868",
                            "ensembl_id": "ENSG00000112053"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-01-25"
            },
            "entity_type": "gene",
            "entity_name": "SLC26A8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "23582645",
                "34923715",
                "35181959"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 3, MIM# 606766"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18130",
                "gene_name": "synaptonemal complex protein 3",
                "omim_gene": [
                    "604759"
                ],
                "alias_name": null,
                "gene_symbol": "SYCP3",
                "hgnc_symbol": "SYCP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:102122426-102133250",
                            "ensembl_id": "ENSG00000139351"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:101728648-101739472",
                            "ensembl_id": "ENSG00000139351"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-02-05"
            },
            "entity_type": "gene",
            "entity_name": "SYCP3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "14643120",
                "19110213"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 4, Recurrent pregnancy loss 4, MIM# 270960"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ECAT1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:33699",
                "gene_name": "KH domain containing 3 like, subcortical maternal complex member",
                "omim_gene": [
                    "611687"
                ],
                "alias_name": [
                    "ES cell associated transcript 1"
                ],
                "gene_symbol": "KHDC3L",
                "hgnc_symbol": "KHDC3L",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:74072400-74073894",
                            "ensembl_id": "ENSG00000203908"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:73362677-73364171",
                            "ensembl_id": "ENSG00000203908"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2012-06-25"
            },
            "entity_type": "gene",
            "entity_name": "KHDC3L",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "21885028",
                "19246479",
                "23232697",
                "31847873",
                "31609975",
                "29606347"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Recurrent hydatidiform mole 2, MIM# 614293"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": null,
                "hgnc_id": "HGNC:20449",
                "gene_name": "peptidyl arginine deiminase 6",
                "omim_gene": [
                    "610363"
                ],
                "alias_name": null,
                "gene_symbol": "PADI6",
                "hgnc_symbol": "PADI6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:17698691-17728195",
                            "ensembl_id": "ENSG00000256049"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:17372196-17401699",
                            "ensembl_id": "ENSG00000276747"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-05-22"
            },
            "entity_type": "gene",
            "entity_name": "PADI6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "29693651",
                "33583041",
                "33221824",
                "27730629",
                "27545678"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Oocyte/zygote/embryo maturation arrest 16, #MIM 617234"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18709",
                "gene_name": "cyclin B3",
                "omim_gene": [
                    "300456"
                ],
                "alias_name": null,
                "gene_symbol": "CCNB3",
                "hgnc_symbol": "CCNB3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:49967364-50094909",
                            "ensembl_id": "ENSG00000147082"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:50202713-50351910",
                            "ensembl_id": "ENSG00000147082"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-05-30"
            },
            "entity_type": "gene",
            "entity_name": "CCNB3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "35722368",
                "32938693",
                "34021051",
                "30770433",
                "34850816"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Recurrent pregnancy loss, susceptibility to, MONDO:0000144, CCNB3-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "p55CDC",
                    "CDC20A"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1723",
                "gene_name": "cell division cycle 20",
                "omim_gene": [
                    "603618"
                ],
                "alias_name": null,
                "gene_symbol": "CDC20",
                "hgnc_symbol": "CDC20",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:43824626-43828874",
                            "ensembl_id": "ENSG00000117399"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:43358955-43363203",
                            "ensembl_id": "ENSG00000117399"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-08-20"
            },
            "entity_type": "gene",
            "entity_name": "CDC20",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "32666501",
                "33683667",
                "33898437",
                "34218387"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Oocyte/zygote/embryo maturation arrest 14, MIM# 620276"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ERIC1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:11524",
                "gene_name": "transforming acidic coiled-coil containing protein 3",
                "omim_gene": [
                    "605303"
                ],
                "alias_name": null,
                "gene_symbol": "TACC3",
                "hgnc_symbol": "TACC3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:1723227-1746898",
                            "ensembl_id": "ENSG00000013810"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:1721490-1745176",
                            "ensembl_id": "ENSG00000013810"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-10-12"
            },
            "entity_type": "gene",
            "entity_name": "TACC3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36395215"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Female infertility due to oocyte meiotic arrest, MONDO:0044626"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ22637"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23113",
                "gene_name": "elongation factor for RNA polymerase II 3",
                "omim_gene": [
                    "609885"
                ],
                "alias_name": null,
                "gene_symbol": "ELL3",
                "hgnc_symbol": "ELL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:44064798-44069741",
                            "ensembl_id": "ENSG00000128886"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:43772600-43777543",
                            "ensembl_id": "ENSG00000128886"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-09-17"
            },
            "entity_type": "gene",
            "entity_name": "ELL3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "39820605"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Pregnancy loss, recurrent, susceptibility to, MONDO:0000144, ELL3-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12785",
                "gene_name": "Wnt family member 6",
                "omim_gene": [
                    "604663"
                ],
                "alias_name": null,
                "gene_symbol": "WNT6",
                "hgnc_symbol": "WNT6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:219724544-219738955",
                            "ensembl_id": "ENSG00000115596"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:218859821-218874233",
                            "ensembl_id": "ENSG00000115596"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-10"
            },
            "entity_type": "gene",
            "entity_name": "WNT6",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36385415",
                "25750203"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "recurrent pregnancy loss susceptibility, MONDO:0000144"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PYPAF8",
                    "MATER",
                    "PAN11",
                    "CLR19.8"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21269",
                "gene_name": "NLR family pyrin domain containing 5",
                "omim_gene": [
                    "609658"
                ],
                "alias_name": [
                    "nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 5",
                    "maternal antigen that embryos require"
                ],
                "gene_symbol": "NLRP5",
                "hgnc_symbol": "NLRP5",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:56511092-56573179",
                            "ensembl_id": "ENSG00000171487"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:55999726-56061813",
                            "ensembl_id": "ENSG00000171487"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-12-08"
            },
            "entity_type": "gene",
            "entity_name": "NLRP5",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30877238",
                "32222962",
                "35091966",
                "35946397",
                "33583041",
                "39887367"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Oocyte/zygote/embryo maturation arrest 19, MIM# 620333"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MISR2",
                    "MISRII"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:465",
                "gene_name": "anti-Mullerian hormone receptor type 2",
                "omim_gene": [
                    "600956"
                ],
                "alias_name": [
                    "Muellerian inhibiting substance type II receptor"
                ],
                "gene_symbol": "AMHR2",
                "hgnc_symbol": "AMHR2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:53817639-53825318",
                            "ensembl_id": "ENSG00000135409"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:53423855-53431534",
                            "ensembl_id": "ENSG00000135409"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-07-22"
            },
            "entity_type": "gene",
            "entity_name": "AMHR2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "7493017",
                "8872466",
                "19457927",
                "35052499",
                "33025551",
                "34480531"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Persistent Mullerian duct syndrome, type I, MIM #261550"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MRP7",
                    "ABC35",
                    "TNR-CFTR",
                    "dJ760C5.1",
                    "CFTR/MRP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1884",
                "gene_name": "cystic fibrosis transmembrane conductance regulator",
                "omim_gene": [
                    "602421"
                ],
                "alias_name": [
                    "ATP-binding cassette sub-family C, member 7"
                ],
                "gene_symbol": "CFTR",
                "hgnc_symbol": "CFTR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:117105838-117356025",
                            "ensembl_id": "ENSG00000001626"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:117465784-117715971",
                            "ensembl_id": "ENSG00000001626"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "CFTR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "30214069",
                "40169970",
                "39592508",
                "39356031"
            ],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Congenital bilateral absence of vas deferens, MIM# 277180"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ13203",
                    "CPEB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21744",
                "gene_name": "cytoplasmic polyadenylation element binding protein 1",
                "omim_gene": [
                    "607342"
                ],
                "alias_name": null,
                "gene_symbol": "CPEB1",
                "hgnc_symbol": "CPEB1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:83211951-83317612",
                            "ensembl_id": "ENSG00000214575"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:82543201-82648861",
                            "ensembl_id": "ENSG00000214575"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-07-22"
            },
            "entity_type": "gene",
            "entity_name": "CPEB1",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "21256485",
                "27003306",
                "33095795",
                "32354341"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Primary ovarian insufficiency, MONDO:0005387, CPEB1-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HHG-3",
                    "MGC35145"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2865",
                "gene_name": "desert hedgehog",
                "omim_gene": [
                    "605423"
                ],
                "alias_name": null,
                "gene_symbol": "DHH",
                "hgnc_symbol": "DHH",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:49483204-49488602",
                            "ensembl_id": "ENSG00000139549"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:49089421-49094819",
                            "ensembl_id": "ENSG00000139549"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-04-28"
            },
            "entity_type": "gene",
            "entity_name": "DHH",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "25927242",
                "28589169",
                "28708305",
                "29471294",
                "40176231"
            ],
            "evidence": [
                "Expert list",
                "Expert Review Green"
            ],
            "phenotypes": [
                "46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome, MONDO:0011766"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "XLHSRF-1",
                    "DNAHC1",
                    "HDHC7",
                    "HL-11",
                    "HL11"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2940",
                "gene_name": "dynein axonemal heavy chain 1",
                "omim_gene": [
                    "603332"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH1",
                "hgnc_symbol": "DNAH1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:52350335-52434507",
                            "ensembl_id": "ENSG00000114841"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:52316319-52400491",
                            "ensembl_id": "ENSG00000114841"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-15"
            },
            "entity_type": "gene",
            "entity_name": "DNAH1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "34867808, 31507630, 24360805, 27798045, 11371505, 27798045, 29449551"
            ],
            "evidence": [
                "ClinGen",
                "Expert Review Green"
            ],
            "phenotypes": [
                "Spermatogenic failure 18, MONDO:0054615"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "hdhc9"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2952",
                "gene_name": "dynein axonemal heavy chain 8",
                "omim_gene": [
                    "603337"
                ],
                "alias_name": null,
                "gene_symbol": "DNAH8",
                "hgnc_symbol": "DNAH8",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:38683117-38998301",
                            "ensembl_id": "ENSG00000124721"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:38715341-39030529",
                            "ensembl_id": "ENSG00000124721"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-11-15"
            },
            "entity_type": "gene",
            "entity_name": "DNAH8",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "31178125, 32619401, 32681648, 33704367"
            ],
            "evidence": [
                "ClinGen",
                "Expert Review Green"
            ],
            "phenotypes": [
                "Spermatogenic failure 46, MONDO:0033673"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ25974",
                    "dJ382I10.1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21405",
                "gene_name": "cilia and flagella associated protein 206",
                "omim_gene": null,
                "alias_name": null,
                "gene_symbol": "CFAP206",
                "hgnc_symbol": "CFAP206",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:88117701-88174183",
                            "ensembl_id": "ENSG00000272514"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:87407983-87464465",
                            "ensembl_id": "ENSG00000272514"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-10-05"
            },
            "entity_type": "gene",
            "entity_name": "CFAP206",
            "confidence_level": "2",
            "penetrance": "unknown",
            "mode_of_pathogenicity": null,
            "publications": [
                "34255152"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure 102, MIM# 621387"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ32828"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14293",
                "gene_name": "tektin 3",
                "omim_gene": [
                    "612683"
                ],
                "alias_name": null,
                "gene_symbol": "TEKT3",
                "hgnc_symbol": "TEKT3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:15207128-15244958",
                            "ensembl_id": "ENSG00000125409"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:15303811-15341641",
                            "ensembl_id": "ENSG00000125409"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-12-22"
            },
            "entity_type": "gene",
            "entity_name": "TEKT3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "36708031"
            ],
            "evidence": [
                "Expert Review Amber",
                "Literature"
            ],
            "phenotypes": [
                "Spermatogenic failure, MONDO:0004983, TEKT3-related"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4455,
                "hash_id": null,
                "name": "Infertility and Recurrent Pregnancy Loss",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "Recurrent pregnancy loss (RPL) and infertility are genetically heterogeneous and overlapping conditions that contribute significantly to adverse reproductive outcomes. This panel has been developed to address the lack of a dedicated diagnostic gene panel specifically targeting recurrent pregnancy loss and/or infertility. This panel includes genes associated with a broad spectrum of male and female infertility phenotypes, as well as those implicated in recurrent pregnancy loss (RPL).\r\n\r\nFor male infertility, it covers genes involved in spermatogenic failure and fertilization defects. For female infertility, it includes genes associated with primary ovarian insufficiency/failure and ovarian dysgenesis. This panel also includes genes associated with infertility phenotypes that affect both sexes, such as hypogonadotropic hypogonadism, gonadal dysgenesis, Persistent Mullerian duct syndrome, and primary ciliary dyskinesia. Genes associated with RPL primarily involve in oocyte, zygote, and embryo maturation arrest (OZEMA), as well as defective implantation and placentation.\r\n\r\nSources used to generate this panel includes literature review and publicly available databases (e.g., OMIM, FeRGI database, Intolerome Gene List).\r\n\r\nPlease also consider the Fetal anomalies panel where appropriate, particularly in cases of pregnancy losses occurring beyond 20 weeks’ gestation.\r\n\r\nWe would like to thank Jasmine Chew (University of Western Australia), Prof Gina Ravenscroft (Harry Perkins Institute of Medical Research), Dr Harmony Clayton (PathWest Laboratory Medicine, Perth) and Audrey Rick (Harry Perkins Institute of Medical Research) for the development of this panel.",
                "status": "public",
                "version": "1.140",
                "version_created": "2026-04-06T10:51:58.181866+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 264,
                    "number_of_strs": 0,
                    "number_of_regions": 1
                },
                "types": [
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    },
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6595",
                "gene_name": "LIM homeobox 3",
                "omim_gene": [
                    "600577"
                ],
                "alias_name": null,
                "gene_symbol": "LHX3",
                "hgnc_symbol": "LHX3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:139088096-139096955",
                            "ensembl_id": "ENSG00000107187"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:136196250-136205109",
                            "ensembl_id": "ENSG00000107187"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-03-22"
            },
            "entity_type": "gene",
            "entity_name": "LHX3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Literature"
            ],
            "phenotypes": [
                "Pituitary hormone deficiency, combined, 3 (MIM#221750)"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CMD1S"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7577",
                "gene_name": "myosin heavy chain 7",
                "omim_gene": [
                    "160760"
                ],
                "alias_name": null,
                "gene_symbol": "MYH7",
                "hgnc_symbol": "MYH7",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:23881947-23904927",
                            "ensembl_id": "ENSG00000092054"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:23412738-23435718",
                            "ensembl_id": "ENSG00000092054"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "MYH7",
            "confidence_level": "2",
            "penetrance": "Complete",
            "mode_of_pathogenicity": "Other",
            "publications": [
                "doi.org/10.1016/j.jacc.2022.07.023",
                "doi.org/10.1038/gim.2017.218"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review"
            ],
            "phenotypes": [
                "Cardiomyopathy, dilated, 1S",
                "Cardiomyopathy, hypertrophic, 1",
                "Congenital myopathy 7A, myosin storage, autosomal dominant",
                "Congenital myopathy 7B, myosin storage, autosomal recessive",
                "Laing distal myopathy",
                "Left ventricular noncompaction 5"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GALA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4296",
                "gene_name": "galactosidase alpha",
                "omim_gene": [
                    "300644"
                ],
                "alias_name": null,
                "gene_symbol": "GLA",
                "hgnc_symbol": "GLA",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:100652791-100662913",
                            "ensembl_id": "ENSG00000102393"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:101397803-101407925",
                            "ensembl_id": "ENSG00000102393"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "GLA",
            "confidence_level": "0",
            "penetrance": "Complete",
            "mode_of_pathogenicity": "Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments",
            "publications": [
                "28613767",
                "37259462"
            ],
            "evidence": [
                "Literature",
                "ClinGen"
            ],
            "phenotypes": [
                "Fabry disease (MIM 301500)",
                "Fabry disease, cardiac variant (MIM 301500)"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "Kir6.2",
                    "BIR"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:6257",
                "gene_name": "potassium voltage-gated channel subfamily J member 11",
                "omim_gene": [
                    "600937"
                ],
                "alias_name": null,
                "gene_symbol": "KCNJ11",
                "hgnc_symbol": "KCNJ11",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:17407406-17410878",
                            "ensembl_id": "ENSG00000187486"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:17385859-17389331",
                            "ensembl_id": "ENSG00000187486"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-09-12"
            },
            "entity_type": "gene",
            "entity_name": "KCNJ11",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "PMID: 28824061",
                "PMID: 32027066",
                "PMID: 21674179",
                "PMID: 38226203",
                "PMID: 26908106"
            ],
            "evidence": [
                "Expert Review Amber",
                "Other"
            ],
            "phenotypes": [
                "Diabetes mellitus, transient neonatal, 3 610582 Diabetes, permanent neonatal, with or without neurologic features 606176 Hyperinsulinemic hypoglycemia, familial, 2 601820"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HIP4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1550",
                "gene_name": "cystathionine-beta-synthase",
                "omim_gene": [
                    "613381"
                ],
                "alias_name": null,
                "gene_symbol": "CBS",
                "hgnc_symbol": "CBS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "21:44473301-44497053",
                            "ensembl_id": "ENSG00000160200"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "21:43053191-43076943",
                            "ensembl_id": "ENSG00000160200"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "CBS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "27778219"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Homocystinuria, B6-responsive and nonresponsive types MIM#236200"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": []
        },
        {
            "gene_data": {
                "alias": [
                    "FIX"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:3551",
                "gene_name": "coagulation factor IX",
                "omim_gene": [
                    "300746"
                ],
                "alias_name": [
                    "Factor IX",
                    "plasma thromboplastic component",
                    "Christmas disease",
                    "hemophilia B"
                ],
                "gene_symbol": "F9",
                "hgnc_symbol": "F9",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:138612917-138645617",
                            "ensembl_id": "ENSG00000101981"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:139530758-139563458",
                            "ensembl_id": "ENSG00000101981"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "F9",
            "confidence_level": "3",
            "penetrance": "Complete",
            "mode_of_pathogenicity": null,
            "publications": [
                "20301668",
                "32809627"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list"
            ],
            "phenotypes": [
                "Haemophilia B, MIM# 306900"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PIG2",
                    "TP53I2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:4136",
                "gene_name": "guanidinoacetate N-methyltransferase",
                "omim_gene": [
                    "601240"
                ],
                "alias_name": null,
                "gene_symbol": "GAMT",
                "hgnc_symbol": "GAMT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:1397091-1401569",
                            "ensembl_id": "ENSG00000130005"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:1397026-1401570",
                            "ensembl_id": "ENSG00000130005"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1996-07-19"
            },
            "entity_type": "gene",
            "entity_name": "GAMT",
            "confidence_level": "3",
            "penetrance": "Complete",
            "mode_of_pathogenicity": null,
            "publications": [
                "36856349",
                "28055022",
                "28055022"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review"
            ],
            "phenotypes": [
                "Creberal creatine deficiency syndrome 2 (MIM 612736)"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:987",
                "gene_name": "branched chain keto acid dehydrogenase E1 subunit beta",
                "omim_gene": [
                    "248611"
                ],
                "alias_name": [
                    "maple syrup urine disease",
                    "2-oxoisovalerate dehydrogenase subunit beta, mitochondrial"
                ],
                "gene_symbol": "BCKDHB",
                "hgnc_symbol": "BCKDHB",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:80816364-81055987",
                            "ensembl_id": "ENSG00000083123"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:80106647-80346270",
                            "ensembl_id": "ENSG00000083123"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1989-06-30"
            },
            "entity_type": "gene",
            "entity_name": "BCKDHB",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Literature",
                "Expert Review"
            ],
            "phenotypes": [
                "Maple syrup urine disease, type Ib, MIM# 248600"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DBA",
                    "S19"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:10402",
                "gene_name": "ribosomal protein S19",
                "omim_gene": [
                    "603474"
                ],
                "alias_name": [
                    "Diamond-Blackfan anemia"
                ],
                "gene_symbol": "RPS19",
                "hgnc_symbol": "RPS19",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:42363988-42376994",
                            "ensembl_id": "ENSG00000105372"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:41859918-41872926",
                            "ensembl_id": "ENSG00000105372"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-22"
            },
            "entity_type": "gene",
            "entity_name": "RPS19",
            "confidence_level": "0",
            "penetrance": null,
            "mode_of_pathogenicity": null,
            "publications": [
                "20301769",
                "30503522"
            ],
            "evidence": [
                "Expert Review"
            ],
            "phenotypes": [
                "Diamond-Blackfan Anemia"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 4456,
                "hash_id": null,
                "name": "Genomic newborn screening: ICoNS",
                "disease_group": "Screening",
                "disease_sub_group": "",
                "description": "UNDER CONSTRUCTION. DO NOT USE.",
                "status": "public",
                "version": "0.35",
                "version_created": "2026-03-13T07:28:16.180055+11:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 20,
                    "number_of_strs": 0,
                    "number_of_regions": 0
                },
                "types": [],
                "child_panel_ids": []
            },
            "transcript": null
        }
    ]
}